These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 18650390)

  • 1. Molecular and cellular signatures of human vaccine adjuvants.
    Mosca F; Tritto E; Muzzi A; Monaci E; Bagnoli F; Iavarone C; O'Hagan D; Rappuoli R; De Gregorio E
    Proc Natl Acad Sci U S A; 2008 Jul; 105(30):10501-6. PubMed ID: 18650390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action.
    Caproni E; Tritto E; Cortese M; Muzzi A; Mosca F; Monaci E; Baudner B; Seubert A; De Gregorio E
    J Immunol; 2012 Apr; 188(7):3088-98. PubMed ID: 22351935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect.
    Calabro S; Tritto E; Pezzotti A; Taccone M; Muzzi A; Bertholet S; De Gregorio E; O'Hagan DT; Baudner B; Seubert A
    Vaccine; 2013 Jul; 31(33):3363-9. PubMed ID: 23684834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of licensed vaccine adjuvants.
    Tritto E; Mosca F; De Gregorio E
    Vaccine; 2009 May; 27(25-26):3331-4. PubMed ID: 19200813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination.
    Vono M; Taccone M; Caccin P; Gallotta M; Donvito G; Falzoni S; Palmieri E; Pallaoro M; Rappuoli R; Di Virgilio F; De Gregorio E; Montecucco C; Seubert A
    Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21095-100. PubMed ID: 24324152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells.
    Cioncada R; Maddaluno M; Vo HTM; Woodruff M; Tavarini S; Sammicheli C; Tortoli M; Pezzicoli A; De Gregorio E; Carroll MC; D'Oro U; Piccioli D
    PLoS One; 2017; 12(10):e0185843. PubMed ID: 29088224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetic and biodistribution study of two distinct squalene-containing oil-in-water emulsion adjuvants in H5N1 influenza vaccines.
    Tegenge MA; Von Tungeln LS; Anderson SA; Mitkus RJ; Vanlandingham MM; Forshee RA; Beland FA
    Regul Toxicol Pharmacol; 2019 Nov; 108():104436. PubMed ID: 31381939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.
    Valensi JP; Carlson JR; Van Nest GA
    J Immunol; 1994 Nov; 153(9):4029-39. PubMed ID: 7930610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells.
    Seubert A; Monaci E; Pizza M; O'Hagan DT; Wack A
    J Immunol; 2008 Apr; 180(8):5402-12. PubMed ID: 18390722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88.
    Seubert A; Calabro S; Santini L; Galli B; Genovese A; Valentini S; Aprea S; Colaprico A; D'Oro U; Giuliani MM; Pallaoro M; Pizza M; O'Hagan DT; Wack A; Rappuoli R; De Gregorio E
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11169-74. PubMed ID: 21690334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvants in influenza vaccines.
    Tetsutani K; Ishii KJ
    Vaccine; 2012 Dec; 30(52):7658-61. PubMed ID: 23084848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes.
    Calabro S; Tortoli M; Baudner BC; Pacitto A; Cortese M; O'Hagan DT; De Gregorio E; Seubert A; Wack A
    Vaccine; 2011 Feb; 29(9):1812-23. PubMed ID: 21215831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders.
    Robinson C; Baehr C; Schmiel SE; Accetturo C; Mueller DL; Pravetoni M
    Hum Vaccin Immunother; 2019; 15(4):909-917. PubMed ID: 30625019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells internalize vaccine adjuvant after intramuscular injection.
    Dupuis M; Murphy TJ; Higgins D; Ugozzoli M; van Nest G; Ott G; McDonald DM
    Cell Immunol; 1998 May; 186(1):18-27. PubMed ID: 9637761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternative renewable source of squalene for use in emulsion adjuvants.
    Brito LA; Chan M; Baudner B; Gallorini S; Santos G; O'Hagan DT; Singh M
    Vaccine; 2011 Aug; 29(37):6262-8. PubMed ID: 21723355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
    Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles.
    O'Hagan DT; Ott GS; Van Nest G
    Mol Med Today; 1997 Feb; 3(2):69-75. PubMed ID: 9060004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake.
    Liang F; Lindgren G; Sandgren KJ; Thompson EA; Francica JR; Seubert A; De Gregorio E; Barnett S; O'Hagan DT; Sullivan NJ; Koup RA; Seder RA; Loré K
    Sci Transl Med; 2017 Jun; 9(393):. PubMed ID: 28592561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway.
    Kim EH; Woodruff MC; Grigoryan L; Maier B; Lee SH; Mandal P; Cortese M; Natrajan MS; Ravindran R; Ma H; Merad M; Gitlin AD; Mocarski ES; Jacob J; Pulendran B
    Elife; 2020 Jun; 9():. PubMed ID: 32515732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.
    Ko EJ; Lee YT; Kim KH; Jung YJ; Lee Y; Denning TL; Kang SM
    J Virol; 2016 Aug; 90(15):6976-6988. PubMed ID: 27226368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.